Annual Retained Earnings
-$993.26 M
-$614.93 M-162.54%
December 31, 2023
Summary
- As of February 12, 2025, SMMT annual retained earnings is -$993.26 million, with the most recent change of -$614.93 million (-162.54%) on December 31, 2023.
- During the last 3 years, SMMT annual retained earnings has fallen by -$782.31 million (-370.86%).
- SMMT annual retained earnings is now -1146849.19% below its all-time high of -$86.60 thousand, reached on January 31, 2005.
Performance
SMMT Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.15 B
-$56.25 M-5.13%
September 30, 2024
Summary
- As of February 12, 2025, SMMT quarterly retained earnings is -$1.15 billion, with the most recent change of -$56.25 million (-5.13%) on September 30, 2024.
- Over the past year, SMMT quarterly retained earnings has dropped by -$56.25 million (-5.13%).
- SMMT quarterly retained earnings is now -1331736.03% below its all-time high of -$86.60 thousand, reached on January 1, 2005.
Performance
SMMT Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
SMMT Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -162.5% | -5.1% |
3 y3 years | -370.9% | -204.9% |
5 y5 years | -895.2% | -873.5% |
SMMT Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -231.6% | at low | -285.0% | at low |
5 y | 5-year | -509.3% | at low | -873.5% | at low |
alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Summit Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$1.15 B(+5.1%) |
Jun 2024 | - | -$1.10 B(+5.8%) |
Mar 2024 | - | -$1.04 B(+4.4%) |
Dec 2023 | -$993.26 M(+162.5%) | -$993.26 M(+3.8%) |
Sep 2023 | - | -$956.69 M(+2.3%) |
Jun 2023 | - | -$935.42 M(+1.6%) |
Mar 2023 | - | -$920.71 M(+143.4%) |
Dec 2022 | -$378.33 M(+26.3%) | -$378.33 M(+5.4%) |
Sep 2022 | - | -$359.10 M(+6.3%) |
Jun 2022 | - | -$337.72 M(+5.2%) |
Mar 2022 | - | -$320.94 M(+7.1%) |
Dec 2021 | -$299.55 M(+42.0%) | -$299.55 M(+9.9%) |
Sep 2021 | - | -$272.45 M(+6.7%) |
Jun 2021 | - | -$255.43 M(+10.3%) |
Mar 2021 | - | -$231.55 M(+9.8%) |
Dec 2020 | -$210.95 M(+29.4%) | - |
Dec 2020 | - | -$210.95 M(+2.3%) |
Sep 2020 | - | -$206.21 M(+62.7%) |
Mar 2020 | - | -$126.78 M(+7.0%) |
Dec 2019 | -$163.01 M(+63.3%) | - |
Oct 2019 | - | -$118.47 M(+14.8%) |
Jul 2019 | - | -$103.23 M(-0.0%) |
Apr 2019 | - | -$103.26 M(+3.5%) |
Jan 2019 | -$99.81 M(-24.9%) | - |
Jan 2019 | - | -$99.81 M(-3.4%) |
Oct 2018 | - | -$103.28 M(+7.5%) |
Jul 2018 | - | -$96.07 M(-30.1%) |
Apr 2018 | - | -$137.40 M(+3.4%) |
Jan 2018 | -$132.95 M(+44.2%) | - |
Jan 2018 | - | -$132.95 M(+45.0%) |
Oct 2017 | - | -$91.66 M(+3.2%) |
Jul 2017 | - | -$88.86 M(-12.5%) |
Apr 2017 | - | -$101.54 M(+10.1%) |
Jan 2017 | -$92.21 M(+23.6%) | - |
Jan 2017 | - | -$92.21 M(+9.7%) |
Oct 2016 | - | -$84.06 M(+8.2%) |
Jul 2016 | - | -$77.69 M(+1.1%) |
Apr 2016 | - | -$76.85 M |
Date | Annual | Quarterly |
---|---|---|
Jan 2016 | -$74.62 M(+53.5%) | - |
Jan 2016 | - | -$74.62 M(+14.3%) |
Oct 2015 | - | -$65.29 M(+11.1%) |
Jul 2015 | - | -$58.75 M(+13.3%) |
Apr 2015 | - | -$51.86 M(+6.7%) |
Jan 2015 | -$48.60 M(-34.8%) | - |
Jan 2015 | - | -$48.60 M(+11.5%) |
Oct 2014 | - | -$43.58 M(-49.5%) |
Jul 2014 | - | -$86.38 M(+15.9%) |
Jan 2014 | -$74.53 M(+20.7%) | - |
Jan 2014 | - | -$74.53 M(+18.6%) |
Jul 2013 | - | -$62.83 M(+1.8%) |
Jan 2013 | -$61.74 M(+12.8%) | - |
Jan 2013 | - | -$61.74 M(+5.9%) |
Jul 2012 | - | -$58.28 M(+6.4%) |
Jan 2012 | -$54.75 M(+7.5%) | - |
Jan 2012 | - | -$54.75 M(-0.7%) |
Jul 2011 | - | -$55.16 M(+8.3%) |
Jan 2011 | -$50.91 M(+16.0%) | - |
Jan 2011 | - | -$50.91 M(+10.8%) |
Jul 2010 | - | -$45.94 M(+4.6%) |
Jan 2010 | -$43.90 M(-16.9%) | - |
Jan 2010 | - | -$43.90 M(-34.0%) |
Jul 2009 | - | -$66.57 M(+26.0%) |
Jan 2009 | -$52.84 M(+86.4%) | - |
Jan 2009 | - | -$52.84 M(+24.8%) |
Jul 2008 | - | -$42.33 M(+49.3%) |
Jan 2008 | -$28.35 M(+249.6%) | - |
Jan 2008 | - | -$28.35 M(+77.9%) |
Jul 2007 | - | -$15.93 M(+96.5%) |
Jan 2007 | -$8.11 M(+307.8%) | - |
Jan 2007 | - | -$8.11 M(+90.4%) |
Jul 2006 | - | -$4.26 M(+114.1%) |
Jan 2006 | -$1.99 M(+2196.3%) | - |
Jan 2006 | - | -$1.99 M(+578.7%) |
Jul 2005 | - | -$293.00 K(+238.3%) |
Jan 2005 | -$86.60 K | - |
Jan 2005 | - | -$86.60 K(-59.7%) |
Jul 2004 | - | -$215.00 K |
FAQ
- What is Summit Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Summit Therapeutics?
- What is Summit Therapeutics annual retained earnings year-on-year change?
- What is Summit Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Summit Therapeutics?
- What is Summit Therapeutics quarterly retained earnings year-on-year change?
What is Summit Therapeutics annual retained earnings?
The current annual retained earnings of SMMT is -$993.26 M
What is the all time high annual retained earnings for Summit Therapeutics?
Summit Therapeutics all-time high annual retained earnings is -$86.60 K
What is Summit Therapeutics annual retained earnings year-on-year change?
Over the past year, SMMT annual retained earnings has changed by -$614.93 M (-162.54%)
What is Summit Therapeutics quarterly retained earnings?
The current quarterly retained earnings of SMMT is -$1.15 B
What is the all time high quarterly retained earnings for Summit Therapeutics?
Summit Therapeutics all-time high quarterly retained earnings is -$86.60 K
What is Summit Therapeutics quarterly retained earnings year-on-year change?
Over the past year, SMMT quarterly retained earnings has changed by -$56.25 M (-5.13%)